# Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms

> **NCT05028153** · PHASE2 · RECRUITING · sponsor: **Copenhagen Studies on Asthma in Childhood** · enrollment: 320 (estimated)

## Conditions studied

- Childhood Asthma With Acute Exacerbation

## Interventions

- **DRUG:** Azithromycin Oral Liquid Product
- **OTHER:** Placebo mixture

## Key facts

- **NCT ID:** NCT05028153
- **Lead sponsor:** Copenhagen Studies on Asthma in Childhood
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-14
- **Primary completion:** 2026-11-13
- **Final completion:** 2032-11-13
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05028153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05028153, "Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05028153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*